Amy S Kelley1, Laura C Hanson2, Katherine Ast3, Elizabeth L Ciemins4, Stephan C Dunning5, Chris Meskow4, Christine S Ritchie6. 1. Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: amy.kelley@mssm.edu. 2. Division of Geriatric Medicine, Palliative Care Program, University of North Carolina School of Medicine, Chapel Hill, NC. 3. American Academy of Hospice and Palliative Medicine, Chicago, IL. 4. AMGA (American Medical Group Association), Alexandria, VA. 5. OptumLabs, Eden Prairie, MN. 6. Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Abstract
CONTEXT: Palliative care can improve the lives of people with serious illness, yet clear operational definitions of this population do not exist. Prior efforts to identify this population have not focused on Medicare Advantage (MA) and commercial health plan enrollees. OBJECTIVES: We aimed to operationalize our conceptual definition of serious illness to identify those with serious medical conditions (SMC) among commercial insurance and MA enrollees, and to compare the populations identified through electronic health record (EHR) or claims data sources. METHODS: We used de-identified claims and EHR data from the OptumLabs Data Warehouse (2016-2017), to identify adults age ≥18 with SMC and examine their utilization and mortality. Within the subset found in both data sources, we compared the performance of claims and EHR data. RESULTS: Within claims, SMC was identified among 10% of those aged ≥18 (5.4% ages 18-64, 27% age ≥65). Within EHR, SMC was identified among 9% of those aged ≥18 (5.6% ages 18-64, 21% ages ≥65). Hospital, emergency department and mortality rates were similar between the EHR and claims-based groups. Only 50% of people identified as having SMC were recognized by both data sources. CONCLUSION: These results demonstrate the feasibility of identifying adults with SMC in a commercially insured population, including MA enrollees; yet separate use of EHR or claims result in populations that differ. Future research should examine methods to combine these data sources to optimize identification and support population management, quality measurement, and research to improve the care of those living with serious illness. Published by Elsevier Inc.
CONTEXT: Palliative care can improve the lives of people with serious illness, yet clear operational definitions of this population do not exist. Prior efforts to identify this population have not focused on Medicare Advantage (MA) and commercial health plan enrollees. OBJECTIVES: We aimed to operationalize our conceptual definition of serious illness to identify those with serious medical conditions (SMC) among commercial insurance and MA enrollees, and to compare the populations identified through electronic health record (EHR) or claims data sources. METHODS: We used de-identified claims and EHR data from the OptumLabs Data Warehouse (2016-2017), to identify adults age ≥18 with SMC and examine their utilization and mortality. Within the subset found in both data sources, we compared the performance of claims and EHR data. RESULTS: Within claims, SMC was identified among 10% of those aged ≥18 (5.4% ages 18-64, 27% age ≥65). Within EHR, SMC was identified among 9% of those aged ≥18 (5.6% ages 18-64, 21% ages ≥65). Hospital, emergency department and mortality rates were similar between the EHR and claims-based groups. Only 50% of people identified as having SMC were recognized by both data sources. CONCLUSION: These results demonstrate the feasibility of identifying adults with SMC in a commercially insured population, including MA enrollees; yet separate use of EHR or claims result in populations that differ. Future research should examine methods to combine these data sources to optimize identification and support population management, quality measurement, and research to improve the care of those living with serious illness. Published by Elsevier Inc.
Entities:
Keywords:
Health services research; medicare advantage; palliative care
Authors: Keturah R Faurot; Michele Jonsson Funk; Virginia Pate; M Alan Brookhart; Amanda Patrick; Laura C Hanson; Wendy Camelo Castillo; Til Stürmer Journal: Pharmacoepidemiol Drug Saf Date: 2014-10-21 Impact factor: 2.890
Authors: Susan Enguidanos; Anna Rahman; Torrie Fields; Wendy Mack; Richard Brumley; Michael Rabow; Melissa Mert Journal: J Pain Symptom Manage Date: 2020-06-24 Impact factor: 3.612
Authors: Amy S Kelley; Kenneth E Covinsky; Rebecca J Gorges; Karen McKendrick; Evan Bollens-Lund; R Sean Morrison; Christine S Ritchie Journal: Health Serv Res Date: 2016-03-18 Impact factor: 3.402
Authors: Dae Hyun Kim; Sebastian Schneeweiss; Robert J Glynn; Lewis A Lipsitz; Kenneth Rockwood; Jerry Avorn Journal: J Gerontol A Biol Sci Med Sci Date: 2018-06-14 Impact factor: 6.053
Authors: Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: Michael Rabow; Elizabeth Kvale; Lisa Barbour; J Brian Cassel; Susan Cohen; Vicki Jackson; Carol Luhrs; Vincent Nguyen; Simone Rinaldi; Donna Stevens; Lynn Spragens; David Weissman Journal: J Palliat Med Date: 2013-11-13 Impact factor: 2.947